LEPU BIO(02157),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02157 LEPU BIO

Not Yet Opened 10-23 16:08:09

3.910

+0.160

+4.27%

High4.000	Low3.570	Vol10.22M
Open3.860	D1 Closing3.750	Amplitude11.47%
Mkt Cap7.05B	Tradable Cap7.05B	Total Shares1.80B
T/O39.22M	T/O Rate0.57%	Tradable Shares1.80B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02157","market":"HK","secType":"STK","nameCN":"LEPU BIO","latestPrice":3.91,"timestamp":1792742889004,"preClose":3.75,"halted":0,"volume":10218000,"delay":0,"changeRate":0.04266666666666671,"floatShares":1804000000,"shares":1804000000,"eps":0.148918,"marketStatus":"Not Yet Opened","change":0.16,"latestTime":"10-23 16:08:09","open":3.86,"high":4,"low":3.57,"amount":39221172,"amplitude":0.114667,"askPrice":3.91,"askSize":4000,"bidPrice":3.9,"bidSize":31000,"shortable":3,"etf":0,"ttmEps":0.15825,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1792978200000},"marketStatusCode":0,"adr":0,"listingDate":1645545600000,"exchange":"SEHK","adjPreClose":3.75,"openAndCloseTimeList":[[1792719000000,1792728000000],[1792731600000,1792742400000]],"volumeRatio":0.7100643822302561,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02157","defaultTab":"news","newsList":[{"id":"1172902077","title":"Nomura Assigns HK$138.29 Target Price and \"Buy\" Rating to Akeso","url":"https://stock-news.laohu8.com/highlight/detail?id=1172902077","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172902077?lang=en_us&edition=fundamental","pubTime":"2026-09-30 15:00","pubTimestamp":1790751617,"startTime":"0","endTime":"0","summary":"Nomura has issued a research report assigning a target price of HK$138.29 and a \"Buy\" rating to Akeso (09926).Nomura noted that before the Hong Kong stock market opened on September 29, Akeso and its...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348783233.USD","LU1961090484.USD","LU0348735423.USD","IE00BPRC5H50.USD","BK1587","BK1583","BK1574","IE00B5MMRT66.SGD","LU0540923850.HKD","LU0348825331.USD","IE00B543WZ88.USD","LU1794554557.SGD","LU2476274720.SGD","02157","LU0634319403.HKD","LU0417516571.SGD","LU0417516738.SGD","LU1720050803.USD","LU0348767384.USD","BK1161","LU2488822045.USD","LU0348784397.USD","KURE","LU2778985437.USD","LU0561508036.HKD","02162","LU0348766576.USD","LU0417516902.SGD","LU2476274308.USD","EWH","09926","LU2399975544.HKD","LU0348827113.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175553010","title":"LEPU BIO Shares Surge Over 4% as CMG901 Clinical Trial Results Selected for Late-Breaking Abstract and to Be Presented at Presidential Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=1175553010","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175553010?lang=en_us&edition=fundamental","pubTime":"2026-09-28 09:56","pubTimestamp":1790560573,"startTime":"0","endTime":"0","summary":"LEPU BIO (02157) shares rose over 4%, reaching 3.56% higher at HK$3.935 as of press time, with a trading turnover of HK$11.9371 million.On the news front, LEPU BIO (02157) announced that at the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","KCAI","VXUS","02157","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131144640","title":"Market Insights for Hong Kong Stocks: Fed Rate Hike Odds for October Approach 70%, and China Successfully Launches 26 Low-Orbit Satellite Internet Satellites","url":"https://stock-news.laohu8.com/highlight/detail?id=1131144640","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131144640?lang=en_us&edition=fundamental","pubTime":"2026-09-24 07:29","pubTimestamp":1790206187,"startTime":"0","endTime":"0","summary":"Top Story: Fed October Rate Hike Probability Nears 70%Overnight and into this morning, a rally in international oil prices, coupled with stronger-than-expected U.S. PMI data, triggered a renewed wave...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOO","HYG",".SPX","CIVG","HK0000252152.HKD","BK1183","SPYQ","02715","VCSH","YSPC","MUNX","VFH","JULD","ZROZ","SPAX","HK0000500386.USD","SPYI","EBUF","JPST","DSPC","BK4561","HMOP","SKRE","SPXU","AGG","LIAJ","TIP","BK1141","SPDN","FLGV","TYO","MARS","VCIT","BK4559","BWZ","BBLB","LU1046422090.SGD","LOFF","BOXX","LU0708995583.HKD","LQDD","02157","BK4588","IEF","LU0469268626.HKD","TNmain","SG9999001093.SGD","FEM","01907","HYGD","FAZ","BK4534","SPUU","TMF","KNCT","VGIT","LU2045819591.USD","DBND","MYCN","LOUP","YSPY","IGOV","BK1551","LU0327786744.USD","BK1576","BSV","UBT","KCAI","XBIL","TBIL","UPRO","KRX","SPAL","EIM","BND","ISHG","LOFD","NGHT","MINT","NEMD","BK4504","SPCI","GSFP","WOOD","SPCF","SPYU","SPXS","UDN","SMAX","SCHO","TFJL","EDV","BK4585","ELOL","ZFmain","IEI","LU2242644610.SGD","TBJL","ESmain","SH","SG9999002950.SGD","ORBX","BIL","VXUS","HAWG","MESmain","LQD","TBT","VEXC","UBmain","BOND","BK4535","LU0320764599.SGD","SPCG","WSPC","BK1161","XSHP","MMAX","OEX","DIPR","DMAX","LQDU","LU0348767384.USD","XLF","BK4550","LU0572944931.SGD","EMPB","KBE","SPXL","PBDC","BK1514","BK4581","BBSB","BK1583","SPCH","SPCU","SGOV","NELS","TLH","GOVT","SG9999014674.SGD","GOLY","BWX","HYGU","SHY","TLTI","LU0348766576.USD","LU2125910500.SGD","HK0000252160.HKD","IAT","KBWB","BK1223","MUB","OEF","SNK","SPYB","SPYM","HIBL","VGLT","IVV","SPCM","UUP","BK1110","ZBmain","BBIB","XLRI","WAMA","BK1144","00699","SSO","SPYH","LU0052750758.USD","SDS","02359","SPY","GALX","TLT","SHV","TLTW","DPST","XSPC","SPCQ","02689","RAUS","TSYW","FSPC","TLTX","OOQB","KRE","VGSH","USHY","SSPC","GBIL","ZTmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669104028","title":"Lepu Biopharma to Present Four Cancer Drug Trial Results at Oncology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2669104028","media":"MT Newswires Live","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669104028?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:44","pubTimestamp":1790156661,"startTime":"0","endTime":"0","summary":"Lepu Biopharma  said positive results from four studies have been selected for presentations at the 2026 European Society for Medical Oncology  Congress.The ESMO Congress will be held in Madrid, Spain, from October 23 to 27, 2026, a Wednesday bourse filing showed.The trials tested CMG901 for the treatment of gastroesophageal carcinoma, MRG007 for colorectal cancer, MRG003 and HX008 for head and neck squamous cell carcinoma, and the same drug combination for thyroid cancer.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02157","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167526019","title":"LEPU BIO's CMG901 and Other Research Results Selected as Late-Breaking Abstracts at 2026 ESMO Congress, With Four Studies Accepted for Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=1167526019","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167526019?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:41","pubTimestamp":1790152877,"startTime":"0","endTime":"0","summary":"LEPU BIO (02157) has announced that its clinical trial results, including the Phase III study of CMG901, have been selected for presentation at the 2026 European Society for Medical Oncology (ESMO)...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125223612","title":"HK Movers | Innovative Drug Stocks Rally Broadly; LEPU BIO, INNOCARE, AKESO Jump Over 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125223612","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125223612?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:59","pubTimestamp":1789955946,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks rose across the board. $LEPU BIO(02157)$, $INNOCARE(09969)$ and $AKESO(09926)$ gained over 7%, while $REMEGEN(09995)$, $EVEREST MED(01952)$, $INNOVENT BIO(01801)$, $GENSCRIPT BIO(01548)$ and $SKB BIO(06990)$ rose over 6%, $3SBIO(01530)$ advanced over 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","01548","01530","02157","01952","09926","09995","06990","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668954981","title":"Chinese Healthcare Platform 111 Inc Q2 Revenue Falls 28% on Asset-Light Shift","url":"https://stock-news.laohu8.com/highlight/detail?id=2668954981","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668954981?lang=en_us&edition=fundamental","pubTime":"2026-09-17 15:12","pubTimestamp":1789629146,"startTime":"0","endTime":"0","summary":"Chinese healthcare platform 111 Inc Q2 revenue falls 28% on asset-light shiftOverviewChina healthcare platform's Q2 revenue fell 28% yr/yr amid asset-light business transitionCompany reported wider ne","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nL1N45907T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","02157","BK4503","YI","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198256689","title":"Lepu Biopharma Interim Results: Product Sales More Than Double, Revenue Up 12%, Profit Slips to RMB24.85 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1198256689","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198256689?lang=en_us&edition=fundamental","pubTime":"2026-09-16 17:08","pubTimestamp":1789549722,"startTime":"0","endTime":"0","summary":"Lepu Biopharma released its 2026 interim report showing revenue rose 12.10% year-on-year to RMB522.41 million, driven by accelerating commercial uptake of MEIYOUHENG (Becotatug Vedotin) and PUYOUHENG...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Lepu Biopharma Interim Results: Product Sales More Than Double, Revenue Up 12%, Profit Slips to RMB24.85 Million","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667761606","title":"China's Lepu Biopharma H1 Revenue Rises 12.1% on Higher Drug Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2667761606","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667761606?lang=en_us&edition=fundamental","pubTime":"2026-09-16 16:42","pubTimestamp":1789548131,"startTime":"0","endTime":"0","summary":"China's Lepu Biopharma H1 revenue rises 12.1% on higher drug salesOverviewChina oncology therapeutics developer's H1 2026 revenue grew 12.1% yr/yrDomestic commercialization revenue more than doubled, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL1N45807H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU2125909247.SGD","LU0114720955.EUR","03165","DFTX","LU2355687059.USD","LU1301847155.USD","IE00BKPKM643.USD","LU1267930573.SGD","LU0310800379.SGD","LU0499090636.EUR","LU0047473722.SGD","LU0128525689.USD","LU1355424745.HKD","LU1496350502.SGD","IE0034235188.USD","LU0640478417.SGD","LU0889566641.SGD","LU1061106388.HKD","LU2089984988.USD","AZN.UK","LU0997586432.USD","IE0002141913.USD","LU1481600234.SGD","LU1119994496.HKD","LU1983299246.USD","LU1989772923.USD","LU0920840948.USD","IE00BFTCPJ56.SGD","LU1267930813.SGD","LU0052756011.USD","LU2125909593.SGD","LU1170363599.USD","LU0211327993.USD","LU1323610961.USD","BK1161","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1003076772.USD","LU1196032939.SGD","LU1153584641.USD","LU0972486137.USD","LU0976567544.SGD","LU2433249047.HKD","LU0784385170.HKD","IE00B3T34201.USD","LU0882574055.USD","LU1496350171.SGD","BK5011","02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667606919","title":"Lepu Biopharma H1 Revenue RMB 371.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2667606919","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667606919?lang=en_us&edition=fundamental","pubTime":"2026-09-16 16:32","pubTimestamp":1789547552,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nPLX07KC1K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02157","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115866351","title":"HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=1115866351","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115866351?lang=en_us&edition=fundamental","pubTime":"2026-09-11 11:13","pubTimestamp":1789096425,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks are experiencing sustained downward pressure in Hong Kong trading. As of the latest update, LEPU BIO (02157) has declined 3.91% to HK$38.05, while REMEGEN (09995) fell...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328277881.USD","IE0008369823.USD","WRTH","09995","LU1807302812.USD","BK1521","LU1152091754.HKD","LU1993786604.SGD","LU2039709279.SGD","BK1589","LU0244354667.USD","LU2097828474.EUR","BK1583","BK1191","BK1515","LU1960683339.HKD","IE00B543WZ88.USD","LU0315179316.USD","LU2097828714.EUR","159992","LU0502904849.HKD","IE00B5MMRT66.SGD","LU0072913022.USD","LU0140636845.USD","KURE","LU1226287875.USD","IE0008368742.USD","IE00BZ08YR35.GBP","LU0880133367.SGD","LNGR","LU1226288170.HKD","LU1226287529.USD","02157","MEDX","LU0067412154.USD","LU1188198961.HKD","LU1951186391.HKD","LU1969619763.USD","BK4585","LU1152091168.USD","IE00BZ08YT58.USD","MCRO","LU1813983027.USD","LU0314109678.HKD","LU1831875114.USD","LU0607220059.USD","LU2242644610.SGD","LU0455707207.USD","LU2097828631.EUR","01093","BK4588","KCAI","LU1226287792.SGD","LU2328871848.SGD","LU1226288253.USD","IE00B031HY20.USD","LU0149534421.HKD","LU2488822045.USD","LU2097828805.USD","SG9999004220.SGD","BK1161","PEVC","06978","BK1574","LU0501845795.SGD","VXUS","LU1008478684.HKD","01801","LU2097828557.USD","IBBQ","LU0326950275.SGD","LU0463099449.HKD","IE00BZ08YS42.EUR","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112946006","title":"LEPU Bio Shares Jump Over 5% in Afternoon Trading on Strong H1 Revenue Growth and Upcoming Full-Cycle BD Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=1112946006","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112946006?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:06","pubTimestamp":1787810812,"startTime":"0","endTime":"0","summary":"LEPU Bio (02157) saw its share price surge more than 5% during the afternoon trading session, before settling at a 3.9% gain to HK$4.13, with trading turnover reaching HK$81.11 million.The company...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","KCAI","BK1161","02157","BK4585","BD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661392202","title":"Lepu Biopharma (SEHK:2157) Stock Grapples With Profit Quality Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2661392202","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661392202?lang=en_us&edition=fundamental","pubTime":"2026-08-21 01:26","pubTimestamp":1787246819,"startTime":"0","endTime":"0","summary":"Lepu Biopharma came into today on the back foot, with the stock down about 10% over the past month, and investors clearly questioning whether the earlier move into profitability can hold. The latest half year report now forces a sentiment reset. Revenue for H1 2026 reached C¥522.4m, yet net income from core operations was only C¥27.4m, a sharp contrast with the recent trailing figures that were lifted by a C¥290.4m one off gain.\nThe market reaction looks less like cool analysis and more like...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-sehk2157-stock-grapples-with-profit-quality-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-sehk2157-stock-grapples-with-profit-quality-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660645445","title":"Lepu Biopharma FY26 H1 Profit Falls 15.2% to RMB 24.8 Million; Revenue Rises 12.1% to RMB 522.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660645445","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660645445?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:38","pubTimestamp":1787128739,"startTime":"0","endTime":"0","summary":"Lepu Biopharma FY26 H1 profit falls 15.2% to RMB 24.8 million; revenue rises 12.1% to RMB 522.4 millionLepu Biopharma posted revenue of RMB 522.4 million, up 12.1% year over year.Profit fell to RMB 24","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL3BbV0H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126980317","title":"LEPU BIO Sets 19 August 2026 Board Meeting to Approve H1 2026 Results and Assess Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1126980317","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126980317?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:25","pubTimestamp":1786101936,"startTime":"0","endTime":"0","summary":"Lepu Biopharma Co., Ltd. (LEPU BIO) has notified the market that its board of directors will convene on 19 August 2026 in Shanghai. The agenda includes: • Reviewing and approving the consolidated...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657106646","title":"Lepu Biopharma Sets Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2657106646","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657106646?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:05","pubTimestamp":1786100759,"startTime":"0","endTime":"0","summary":"Lepu Biopharma sets board meeting to review interim results, consider dividendLepu Biopharma will hold a board meeting on Aug. 19, 2026 to review interim results for the six months ended June 30, 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL1t7jp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117144688","title":"LEPU BIO Maintains 1.80 Billion Issued Shares and Confirms Public Float Compliance for July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1117144688","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117144688?lang=en_us&edition=fundamental","pubTime":"2026-08-03 17:46","pubTimestamp":1785750413,"startTime":"0","endTime":"0","summary":"Lepu Biopharma Co., Ltd. (LEPU BIO) filed its monthly return on movements in securities for the period ended 31 July 2026, indicating that the company’s share structure remained unchanged during the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155595300","title":"Hong Kong Stock Movers: LEPU BIO Surges Nearly 4% After Positive Topline Results from Global Phase III CMG901 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1155595300","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155595300?lang=en_us&edition=fundamental","pubTime":"2026-07-28 15:34","pubTimestamp":1785224086,"startTime":"0","endTime":"0","summary":"LEPU BIO (02157) shares climbed nearly 4% in early trading, briefly surging over 12%. As of press time, the stock was up 3.83% at HK$4.61, with turnover reaching HK$91.6484 million.On July 28, the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK4134","BK4588","MDTX","BK4585","BMED","VXUS","PSYK","KCAI","III","IBBJ","02157","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654078661","title":"Lepu Biopharma Reports Positive Top-Line Results from Global Phase III Trial of Cmg901 (azd0901)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654078661","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654078661?lang=en_us&edition=fundamental","pubTime":"2026-07-28 12:29","pubTimestamp":1785212978,"startTime":"0","endTime":"0","summary":"BRIEF-Lepu Biopharma Reports Positive Top-Line Results From Global Phase III Trial Of CMG901 (AZD0901)July 28 (Reuters)-Lepu Biopharma Co Ltd2157.HK:REPORTS POSITIVE TOP-LINE RESULTS FROM GLOBAL PHASE III TRIAL OF CMG901 (AZD0901)Further company coverage:2157.HK","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nFWN43U00C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654078657","title":"Lepu Biopharma Says Phase III CLARITY-Gastric01 Trial Meets Overall Survival Endpoint for Cmg901 in Late-line Gastric Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2654078657","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654078657?lang=en_us&edition=fundamental","pubTime":"2026-07-28 12:28","pubTimestamp":1785212926,"startTime":"0","endTime":"0","summary":"Lepu Biopharma says Phase III CLARITY-Gastric01 trial meets overall survival endpoint for CMG901 in late-line gastric cancerLepu Biopharma reported positive top-line results from the global Phase III ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDL7k2M9l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02157"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lepubiopharma.com","stockEarnings":[{"period":"1week","weight":0.1108},{"period":"1month","weight":-0.0225},{"period":"3month","weight":-0.1073},{"period":"6month","weight":-0.3055},{"period":"1year","weight":-0.3734},{"period":"ytd","weight":-0.2133}],"compareEarnings":[{"period":"1week","weight":-0.0452},{"period":"1month","weight":-0.0701},{"period":"3month","weight":-0.0749},{"period":"6month","weight":-0.111},{"period":"1year","weight":-0.1107},{"period":"ytd","weight":-0.099}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Lepu Biopharma Co Ltd is a company principally engaged in the sales of pharmaceutical products and the research and development of new drugs. The Company is focused on oncology therapeutics, in particular, targeted therapy and oncology immunotherapy. The Company is dedicated to developing innovative antibody-drug conjugate (ADC) through an ADC technology development platform. The Company’s clinical-stage drug candidates cover targeted therapeutics and an immunotherapeutic, including MRG003, MRG002, CMG901, MRG004A, CG0070, MRG006A, MRG007, and CTM012.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.070458},{"month":2,"riseRate":0.5,"avgChangeRate":0.087235},{"month":3,"riseRate":0.4,"avgChangeRate":-0.009016},{"month":4,"riseRate":0.8,"avgChangeRate":0.177486},{"month":5,"riseRate":0.4,"avgChangeRate":-0.041488},{"month":6,"riseRate":0.4,"avgChangeRate":-0.053819},{"month":7,"riseRate":0.6,"avgChangeRate":0.074049},{"month":8,"riseRate":0.6,"avgChangeRate":0.005043},{"month":9,"riseRate":0.4,"avgChangeRate":0.05935},{"month":10,"riseRate":0.2,"avgChangeRate":-0.128644},{"month":11,"riseRate":0.25,"avgChangeRate":0.007333},{"month":12,"riseRate":0.25,"avgChangeRate":-0.05091}],"exchange":"SEHK","name":"LEPU BIO","nameEN":"LEPU BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LEPU BIO(02157),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LEPU BIO(02157) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LEPU BIO,02157,LEPU BIO股票,LEPU BIO股票老虎,LEPU BIO股票老虎国际,LEPU BIO行情,LEPU BIO股票行情,LEPU BIO股价,LEPU BIO股市,LEPU BIO股票价格,LEPU BIO股票交易,LEPU BIO股票购买,LEPU BIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LEPU BIO(02157),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LEPU BIO(02157) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}